TGCT

Clinical trials for TGCT explained in plain language.

Never miss a new study

Get alerted when new TGCT trials appear

Sign up with your email to follow new studies for TGCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug offers hope for rare joint tumor patients unable to have surgery

Disease control Ongoing

This study tests an investigational drug called emactuzumab for people with tenosynovial giant cell tumor (TGCT), a rare, non-cancerous growth in the joints that can cause pain and stiffness. The trial includes 128 participants who cannot have surgery to remove the tumor. Half re…

Matched conditions: TGCT

Phase: PHASE3 • Sponsor: SynOx Therapeutics Limited • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

TGCT

Get alerted when new TGCT trials appear

New drug offers hope for rare joint tumor patients unable to have surgery